MYRIAD GENETICS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($112.0m) ($263.3m) ($127.3m) ($365.9m)
Net Income (Loss) Attributable to Parent $125.3m $21.8m $131.1m $4.6m ($199.5m) ($27.2m) ($112.0m) ($263.3m) ($127.3m) ($365.9m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $21.6m $130.9m $4.4m ($199.6m) ($27.2m) ($112.0m)
Net Income (Loss) Attributable to Noncontrolling Interest ($200k) ($200k) ($200k) ($100k) $0 $0
Depreciation and amortization $26.7m $48.3m $54.4m $73.0m $72.0m $62.8m $52.7m $61.9m $61.2m $53.7m
Depreciation $14.1m $15.0m $17.1m $13.7m $11.0m $12.1m $11.6m $19.1m $19.5m $19.5m
Amortization of Intangible Assets $12.6m $33.3m $37.3m $59.3m $61.0m $50.7m $41.1m $42.8m $42.1m $34.7m
Capitalized Computer Software, Amortization $200k $1.2m
Depreciation Amortization Depletion $52.7m $61.9m $61.2m $53.7m
Deferred Income Tax Expense (Benefit) $17.9m $1.7m ($22.9m) $19.7m ($55.7m) ($31.7m) ($30.5m) ($4.3m) ($2.3m) $1.4m
Deferred Income Tax ($31.9m) ($600k) ($300k) ($32.4m)
Deferred Tax ($31.9m) ($600k) ($300k) ($32.4m)
Share-based Payment Arrangement, Noncash Expense $31.6m $29.9m $27.1m $33.5m $25.2m $36.3m $38.1m $40.7m $49.8m $35.2m
Payment, Tax Withholding, Share-based Payment Arrangement $9.8m $11.5m $10.6m $8.8m $13.4m $7.3m
Equity Method Investment, Other than Temporary Impairment $0 $0
Goodwill and Intangible Asset Impairment $99.7m $1.8m $16.9m $0 $56.8m $319.4m
Goodwill, Impairment Loss $0 $0 $0 $0 $82.0m $0 $0 $0 $234.7m
Impairment of Intangible Assets (Excluding Goodwill) $0 $99.7m $0 $0 $0 $56.6m $319.4m
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss ($1.5m)
Operating Lease, Impairment Loss $13.0m
Share-based Payment Arrangement, Expensed and Capitalized, Amount $1.9m $2.3m $100k $1.0m $1.7m
Asset Impairment Charge $16.9m $0 $56.6m $319.4m
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $900k $300k $200k $900k $0 $162.0m $0 $0
Gain (Loss) on Extinguishment of Debt ($1.3m)
Income Tax Expense (Benefit) $43.6m $21.3m ($14.0m) ($4.4m) ($23.7m) ($29.9m) ($28.6m) $1.1m $3.8m ($29.2m)
Interest Expense Nonoperating $2.8m $10.5m
Other Nonoperating Income (Expense) $1.2m ($2.5m) ($400k) $1.2m $16.2m $139.3m $600k ($4.4m) $1.1m $800k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $39.2m $41.4m $39.2m $18.2m ($64.0m) $8.8m $10.3m $12.5m $8.7m ($6.2m)
Increase (Decrease) in Inventories $14.6m $1.2m ($7.9m) ($8.0m) ($1.6m) ($1.6m) $2.9m $1.8m $6.2m $3.2m
Increase (Decrease) in Accounts Payable ($3.0m) $4.0m $1.1m ($10.7m) $9.2m ($3.5m) ($3.7m) $4.7m ($1.4m)
Debt Securities, Available-for-sale, Realized Gain (Loss) ($1.5m)
Deconsolidation, Gain (Loss), Amount $1.0m
Foreign Currency Transaction Gain (Loss), before Tax $0 $0 $0 ($3.4m) ($1.1m)
Gain (Loss) on Termination of Lease $0 $0 ($7.7m) $3.1m $0
General and Administrative Expense $275.9m $256.8m
Goodwill $195.3m $316.1m $318.6m $417.2m $327.6m $239.2m $286.8m $287.4m $286.3m $51.6m
Inventory Write-down $6.5m $0 $0
Investment Income, Interest $900k $1.2m $1.8m $3.2m $3.0m $700k $2.6m $2.5m $1.7m $1.8m
Nonoperating Income (Expense) $2.1m ($6.5m) ($1.8m) ($7.6m) $8.4m $133.4m $0 ($4.8m) $0 ($7.9m)
Operating Expenses $708.9m $963.8m
Beginning Cash Position $258.8m $66.4m $140.9m $111.9m
Cash Flow From Continuing Financing Activities ($8.0m) $152.9m ($7.4m) $64.2m
Cash Flow From Continuing Investing Activities ($77.5m) $31.9m ($11.9m) ($27.4m)
Change In Account Payable ($3.5m) ($3.7m) $4.7m ($1.4m)
Change In Accrued Expense ($86.2m) $27.2m ($41.0m) ($27.5m)
Change In Inventory ($2.9m) ($1.8m) ($6.2m) ($3.2m)
Change In Other Current Assets ($900k) $600k $0 $2.0m
Change In Other Working Capital ($26.6m) ($5.0m) ($200k)
Change In Payable ($3.5m) ($3.7m) $4.7m ($1.4m)
Change In Payables And Accrued Expense ($89.7m) $23.5m ($36.3m) ($28.9m)
Change In Prepaid Assets $2.3m $900k ($3.2m) $4.6m
Change In Receivables ($10.3m) ($12.5m) ($8.7m) $6.2m
Change In Working Capital ($101.5m) $10.7m ($54.4m) ($19.3m)
Changes In Account Receivables ($10.3m) ($12.5m) ($8.7m) $6.2m
Changes In Cash ($191.8m) $73.9m ($28.0m) $38.6m
End Cash Position $66.4m $140.9m $111.9m $151.3m
Financing Cash Flow ($8.0m) $152.9m ($7.4m) $64.2m
Free Cash Flow ($151.6m) ($184.2m) ($38.4m) ($25.6m)
Gain Loss On Sale Of Business ($162.0m) $0 $0
Investing Cash Flow ($77.5m) $31.9m ($11.9m) ($27.4m)
Issuance Of Capital Stock $0 $117.6m $0 $0
Net Business Purchase And Sale ($57.2m) $0 $8.8m $0
Net Foreign Currency Exchange Gain Loss $0 $0
Operating Gains Losses ($162.0m) $1.5m
Other Non Cash Items $31.4m $39.7m $5.7m $11.1m
Proceeds From Stock Option Exercised $6.3m $6.0m $5.9m $3.3m
Purchase Of Business $0 ($57.2m) $0 $0
Sale Of Business $0 $0 $8.8m $0
Stock Based Compensation $38.1m $40.7m $49.8m $35.2m
Net Cash Provided by (Used in) Operating Activities $166.3m $106.2m $115.9m $83.7m $60.7m $18.2m ($106.3m) ($110.9m) ($8.7m) $1.8m
Cash flows from investing activities:
Capital Expenditure ($45.3m) ($73.3m) ($29.7m) ($27.4m)
Capital Expenditure Reported $5.0m $6.1m $8.4m $8.6m $7.9m $18.0m ($45.3m) ($73.3m) ($29.7m) ($27.4m)
Payments to Acquire Businesses, Net of Cash Acquired $37.0m $216.1m $278.5m $0 $0 $57.2m $0 $0
Net Investment Purchase And Sale $25.0m $105.2m $9.0m $0
Purchase Of Investment ($147.8m) ($103.2m) $0 $0
Sale Of Investment $128.2m $105.2m $9.0m $0
Net Cash Provided by (Used in) Investing Activities ($91.4m) ($146.3m) ($11.6m) ($286.4m) $19.3m $274.4m ($77.5m) $31.9m ($11.9m) ($27.4m)
Cash flows from financing activities:
Issuance Of Debt $0 $80.0m $120.0m $165.0m
Long Term Debt Issuance $0 $80.0m $120.0m $165.0m
Net Issuance Payments Of Debt $0 $39.8m $100k $84.3m
Net Long Term Debt Issuance $0 $39.8m $100k $84.3m
Long Term Debt Payments $0 ($40.2m) ($119.9m) ($80.7m)
Repayment Of Debt $0 ($40.2m) ($119.9m) ($80.7m)
Common Stock Issuance $0 $117.6m $0 $0
Net Common Stock Issuance $0 $117.6m $0 $0
Payments for Repurchase of Common Stock $162.6m $31.6m $50.0m $0 $0
Proceeds from Noncontrolling Interests $500k $0
Proceeds from (Payments for) Other Financing Activities ($200k)
Net Other Financing Charges ($14.3m) ($10.5m) ($13.4m) ($23.4m)
Net Cash Provided by (Used in) Financing Activities ($68.3m) $71.8m ($95.0m) $182.3m ($10.0m) ($150.6m) ($8.0m) $152.9m ($7.4m) $64.2m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.7m $500k ($600k) ($600k) $600k ($1.0m) $800k
Effect Of Exchange Rate Changes ($600k) $600k ($1.0m) $800k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2.7m $70.5m $141.4m ($192.4m) $74.5m ($29.0m) $39.4m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.7m $163.7m $258.4m $66.4m $140.9m $111.9m $151.3m
Cash, Cash Equivalents, and Short-term Investments $254.8m $398.8m $169.7m $140.9m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($192.4m) $74.5m ($29.0m) $39.4m
Income Tax Paid Supplemental Data $4.6m $1.8m $1.9m $2.7m
Interest Paid, Excluding Capitalized Interest, Operating Activities $3.0m $11.6m $9.5m $4.4m $0 $1.4m $1.9m $8.4m